Resources

Publish Date
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Council for Innovation Promotion
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Council for Innovation Promotion
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing
Council for Innovation Promotion
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology
Council for Innovation Promotion
Issue Briefs
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences
Council for Innovation Promotion
Letters
C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence
Council for Innovation Promotion
Letters
C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions
Council for Innovation Promotion
Infographics
Drug Competition Enhancement Act Infographic
Council for Innovation Promotion
Infographics
Affordable Prescriptions for Patients Act Infographic
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011)
Council for Innovation Promotion
Public Comments
C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program
Council for Innovation Promotion
Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025

C4IP:

C4IP, Resources:

C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month,

10/21/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing,

10/07/2025

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025

Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025

Resources:

Resources:

C4IP Letter to House Judiciary Subcommittee on Courts, Intellectual Property, Artificial Intelligence, and the Internet RE: Artificial Intelligence,

09/18/2025

Resources:

Resources:

C4IP Letter to FTC & DOJ RE: Drug Pricing Listening Sessions,

08/15/2025

Resources:

Resources:

Drug Competition Enhancement Act Infographic,

06/27/2025

Resources:

Resources:

Affordable Prescriptions for Patients Act Infographic,

06/27/2025

Resources:

Resources:

C4IP Comments RE: Foreign Nations Freeloading on American-Financed Innovation (USTR-2025-0011),

06/27/2025

Resources:

Resources:

C4IP Comments RE: Draft Guidance on the Medicare Drug Price Negotiation Program,

06/26/2025

Scroll to Top